PORTSMOUTH, N.H., May 22, 2024
/PRNewswire/ -- MediSpend, a global technology company providing
best-in-class solutions for the life sciences industry, is thrilled
to announce its acquisition of MedCompli, a compliance software
solutions provider focused on simplifying life science compliance
management. This strategic move solidifies MediSpend's commitment
to enhancing client value and empowering life sciences companies to
grow their business compliantly.
The acquisition, effective May 17,
2024, marks a pivotal milestone in MediSpend's growth
strategy, amplifying its global capabilities and enhancing its
technology and subject matter expertise. MedCompli brings strong
subject matter expertise and industry knowledge, as well as a suite
of products that perfectly complement MediSpend's existing
offerings. Developed by experienced compliance officers,
MedCompli's solutions foster a culture of ethical practices while
providing intuitive, configurable and affordable tools for
companies to navigate complex regulations confidently. Together,
MediSpend and MedCompli's combined strengths will revolutionize the
market, delivering more robust and flexible solutions tailored to
the unique needs of life science companies of any size.
Following the acquisition, MediSpend will be the global
commercial compliance technology of record for more than 200 life
sciences companies from around the world. By integrating
purpose-built and highly configurable technology solutions, managed
services and compliance advisory support, MediSpend will now have
the most robust portfolio of solutions in the market designed to
enable life science companies to adhere to the growing compliance
regulations facing the life science industry.
"This is an exciting chapter for the MediSpend team as we
venture into the next phase of expansion," said Craig Hauben, CEO of MediSpend. "MedCompli's
product suite fills gaps in our portfolio, allowing us to provide
our clients with even more comprehensive solutions. By harnessing
our collective expertise, we are better equipped to empower life
sciences companies to grow their business compliantly."
Chris Gingras, President and CEO
of MedCompli, will join MediSpend as Chief Product Strategy
Officer. "At MedCompli, our mission has always been to simplify
compliance management," said Gingras. "As we unite with MediSpend,
I have full confidence that together, we will continue to advance
this mission with even greater impact."
Market Benefits
- Unifying Best-In-Class Technology with Industry-Driven
Expertise: By joining forces, MediSpend integrates its
robust technology with MedCompli's deep industry knowledge. This
collaborative approach ensures clients have access to cutting-edge
technology supported by comprehensive industry expertise.
- Tailored Solutions to Fit Every Business Size: With a
single source of solutions, MediSpend can now tailor offerings to
fit the unique needs of life sciences companies of any size.
Whether it's an emerging life sciences company or a global,
enterprise corporation, clients can rely on MediSpend for solutions
to meet their commercial compliance needs.
- Enriched Knowledge Base: With MedCompli's seasoned
subject matter experts joining MediSpend, the team gains a wealth
of expertise. From technology innovations to industry best
practices, MediSpend is equipped to effectively tackle any
challenge.
About MediSpend
MediSpend is a global technology company providing best-in-class
solutions that empower life sciences companies to grow their
business compliantly through top-rated software and client
services. MediSpend is the compliance system of record for some of
the world's largest pharmaceutical, medical device, dental and
emerging biotech companies around the world. The MediSpend Global
Compliance Suite represents the industry's first global SaaS
solution purpose-built to manage the end-to-end process of HCP/O
engagement through transparency reporting, which includes software
that facilitates external grant requests. MediSpend is
headquartered in Portsmouth, N.H.
Visit MediSpend online at www.medispend.com.
About MedCompli
MedCompli is committed to revolutionizing the healthcare, life
science, and pharmaceutical industries by offering innovative
software solutions that simplify compliance management. Developed
by experienced compliance officers, MedCompli's solutions foster a
culture of ethical practices and work-life balance while providing
intuitive, configurable, and affordable tools for organizations to
navigate complex regulations confidently.
Media Contact
Seth Houston
shouston@medispend.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/revolutionizing-commercial-compliance-for-life-sciences-medispends-strategic-acquisition-of-medcompli-302152938.html
SOURCE MediSpend